DEF 14A

Company

Acurx Pharmaceuticals, Inc.

Filed

August 4, 2025

Period of Report

September 16, 2025

Accession Number

0001104659-25-073623

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →